Atopic dermatitis highlights from AAD 2025 include phase 3 trial results on rocatinlimab and delgocitinib, findings on tapinarof 1% cream, and early dosing data on a new JAK1/TYK2 inhibitor.
Struggling with dark spots? Learn what causes hyperpigmentation, how to prevent it, and the best treatments—from skincare ...
Scientists at CNIC have identified a specialized group of neutrophils in the skin that produce extracellular matrix. This activity helps reinforce the skin’s barrier and enhances its ability to defend ...
A new randomized clinical trial investigates whether 3D total-body photography improves melanoma detection and impacts biopsy rates in high-risk patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback